Hi

On the other side of pain, is progress!

And I'm delighted to share every ounce of pain has been worth it with our recent progress in the development and commercialisation of MindBio's Voice AI drug and alcohol intoxication detection technology developed during clinical trials.

I am pleased to report we have interest from health and mining executives in South America to deploy an enterprise version of the technology in the mining industry in South America. We are currently working with South American counterparts on a protocol to deploy the technology for the testing of hundreds of thousands of mining workers.

Drug and Alcohol Related Accidents Can Cost $100's of Millions in Delayed Production.

Drug and alcohol testing in the mining industry is serious business. In Chile alone, 75% of the industry's 200,000 plus workers are consumers of alcohol with 40% being problematic drinking and 9% consuming illicit drugs. A single accident can stop production for weeks, costing $100's of million in production delays, union stoppages and escalating insurance and health costs. Drug and alcohol testing is an essential part of health and safety in mining operations.

Current Testing is Expensive, Invasive, Time Consuming and not Scalable.

The industry has a huge problem to deal with in drug and alcohol intoxication detection because it is time consuming, expensive, invasive and it is difficult to do a broad screen for a range of drugs and alcohol at scale with just one test. So, random testing is implemented using saliva, urine, blood samples plus breath testing. The current system is not scalable.

MindBio's Voice AI Solution is a Scalable Solution and First Screening Opportunity at the Gate.

MindBio is investing heavily in Voice AI intoxication detection tools backed by years of clinical trials and data collection, and this work has accelerated post our recent successful placement offering allowing the company to invest heavily in developing the technology into a scalable enterprise platform to serve a number of industries.

The Company is developing a bespoke solution for the mining industry and with support from our South American counterparts will revolutionise drug and alcohol detection in the mining industry that will have a significant impact on MindBio's commercial opportunity in the mining and other industries globally.

MindBio Now Listed for Trading on OTCQB Market in USA: Ticker MBQIF

The Company recently listed for trading on the OTCQB market in USA under the ticker MBQIF. The result is a broader investor audience and more liquidity for the stock.

This very exciting opportunity for MindBio will revolutionise drug and alcohol intoxication detection globally in the mining industry.

We have a first mover advantage in Voice initiated health diagnostics with the technology already in commercialisation.

I want to thank everyone that has assisted us including our incredible investors to transform the company to the significant commercial opportunity that has emerged and ahead of us.

Stay Well!

JUSTIN HANKA

Chief Executive Officer

MindBio Therapeutics Corp

(CNSX: MBIO) (Frankfurt: WF6) (OTCQB: MBQIF)